The Pharmaceutical Benefits Advisory Committee will consider new proposals from MSD and Bristol Myers Squibb at its July meeting to accelerate reimbursement of approved indications for their immunotherapies. …
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News -
You certainly couldn't accuse this system of haste, and this might need ministerial intervention
June 9, 2025 - - Latest News -
Early intervention on chronic kidney disease would deliver economic boost
June 8, 2025 - - Latest News -
Australian Dementia Network, Monash University and Lilly sign research collaboration
June 6, 2025 - - Latest News -
The Dispatched Podcast - 6 June
June 6, 2025 - - Podcast -
Health department amends published blood review information
June 5, 2025 - - Latest News -
'My experience was awful, I really had to fight to be taken seriously and advocate for myself'
June 5, 2025 - - Latest News